Narcolepsy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Narcolepsy stocks.

Narcolepsy Stocks Recent News

Date Stock Title
May 2 HRMY Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences is a Solid Choice
May 2 ZVRA Will OptiNose (OPTN) Report Negative Q1 Earnings? What You Should Know
May 2 TEVA Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
May 2 TEVA Q1 2024 Corcept Therapeutics Inc Earnings Call
May 2 TEVA Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
May 2 JAZZ Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Call Transcript
May 1 JAZZ Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
May 1 JAZZ Jazz Pharmaceuticals plc 2024 Q1 - Results - Earnings Call Presentation
May 1 JAZZ Jazz Pharmaceuticals misses top-line and bottom-line estimates; reaffirms FY24 outlook
May 1 JAZZ Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
May 1 JAZZ Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
May 1 HRMY Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice
May 1 HRMY HRMY or TECH: Which Is the Better Value Stock Right Now?
May 1 HRMY Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript
May 1 AVDL Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8
May 1 ZVRA Zevra Therapeutics to Report First Quarter 2024 Results on May 8, 2024
Apr 30 HRMY Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
Apr 30 JAZZ Jazz Pharmaceuticals Q1 2024 Earnings Preview
Apr 30 HRMY Harmony Biosciences: Company's Q1 Update Music To Investor Ears (Upgrade)
Apr 30 HRMY Harmony Biosciences Holdings, Inc (HRMY) Q1 2024 Earnings Call Transcript
Narcolepsy

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of those affected also experience episodes of sudden loss of muscle strength, known as cataplexy. These experiences can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.The exact cause of narcolepsy is unknown, with potentially several causes. In up to 10% of cases, there is a family history of the disorder. Often, those affected have low levels of the neuropeptide orexin, which may be due to an autoimmune disorder. Trauma, infections, toxins or psychological stress may also play a role. Diagnosis is typically based on the symptoms and sleep studies, after ruling out other potential causes. Excessive daytime sleepiness can also be caused by other sleep disorders such as sleep apnea, major depressive disorder, anemia, heart failure, drinking alcohol and not getting enough sleep. Cataplexy may be mistaken for seizures.While there is no cure, a number of lifestyle changes and medications may help. Lifestyle changes include taking regular short naps and sleep hygiene. Medications used include modafinil, sodium oxybate and methylphenidate. While initially effective, tolerance to the benefits may develop over time. Tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs) may improve cataplexy.About 0.2 to 600 per 100,000 people are affected. The condition often begins in childhood. Men and women are affected equally. Untreated narcolepsy increases the risk of motor vehicle collisions and falls. The term "narcolepsy" is from the French narcolepsie. The French term was first used in 1880 by Jean-Baptiste-Édouard Gélineau, who used the Greek νάρκη (narkē), meaning "numbness", and λῆψις (lepsis) meaning "attack".

Browse All Tags